Comparison of the adsorption ability between tryptophan and modified tryptophan columns

Therapeutic Apheresis

Volumn 1, Issue 4, 1997, Pages 353-355

  Odaka, Masaaki ^a   Yuki, Nobuhiro ^a   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiganglioside antibody; Guillain Barr syndrome; Immunoadsorption therapy; Modified tryptophan column; Tryptophan column

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE; IMMUNOGLOBULIN G; TRYPTOPHAN;

ADSORPTION; ARTICLE; COMPARATIVE STUDY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; POLYRADICULONEUROPATHY;

ADSORPTION; AUTOANTIBODIES; ENCEPHALITIS; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MILLER FISHER SYNDROME; POLYRADICULONEUROPATHY; TRYPTOPHAN;

EID: 0031261169     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00054.x     Document Type: Review

References (15)

1. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35: 1096-1104.
2. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: Role of replacement fluids. Ann Neurol 1987;22:753-61.
3. Thornton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994;35:260-8.
4. Ilyas AA, Willison HJ, Quarles R, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988;23:440-7.
5. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-2.
6. Latov N, Koski CL, Walicke PA. Guillain-Barré syndrome and parenteral ganglioside. Lancet 1991;338:757.
7. Landi G. D'Alessando R, Dossi BC, Ricci S, Simone IL, Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. Br Med J 1993;307:1463-4.
8. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993;16:587-93.
9. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-42.
10. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1bIgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology 1993;43:1911-7.
11. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaffs brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993;118:83-7.
12. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 1996;39:668-72.
13. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher' syndrome: A new approach to treatment. Neurology 1996;46:1644-51.
14. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 α. J Neuroimimmol 1997;74:30-4.
15. The French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome: Appropriate number of plasma exchange in Guillain-Barré syndrome. Ann Neurol 1997;41: 298-306.